CIDRAP newsletters options
A new systematic review and meta-analysis of three randomized clinical trials with 2,196 patients suggests that early use of the antidepressant fluvoxamine reduces the risk of all-cause hospitalization in symptomatic adult outpatients.
"It is sobering to see how many health care workers are troubled at a moral level."
Among SARS-CoV-2 isolates, 99.8% are Omicron, and 93.6% of those are the faster-spreading BA.2 subvariant.
The White House plan includes increased funding, clinician education, bolstered healthcare coverage, and expansion of clinics.
Observational research set to be presented later this month at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) suggests close contact with pets could result in sharing of multidrug-resistant bacteria and resistance genes.
A study in Israel during the Omicron variant surge finds that rates of COVID-19 infection and severe illness were lower after a fourth dose of the Pfizer/BioNTech vaccine than after three doses, and while protection against infection waned quickly after 4 weeks, protection against severe disease was still strong at 6 weeks.
Also, pandemic response coordinator Jeff Zients calls a $10 billion funding package only "a start."
Vaccination is not linked to fetal abnormalities detectable on ultrasound, study finds.
"Given the limited resources countries have, we need a new strategy."
An analysis of antibiotic use for upper respiratory infections (URIs) in Ghana reveals the considerable economic impact of inappropriate prescribing can have on low-resource settings, researchers reported last week in Antimicrobial Resistance & Infection Control.
Two new studies detail long COVID symptoms, with one from France showing that 85% of patients who had symptoms 2 months after illness onset still had them at 1 year and some symptoms worsened, and one from China revealing that 12% of patients reported rheumatic symptoms at 1-year follow-up.
In global COVID news, Shanghai's lockdown will be extended.
Adaptive Phage Therapeutics and Venatorx Pharmaceuticals are the first grant recipients.
The outbreak in Texas marks the southernmost spread to poultry so far.
A new study in JAMA Pediatrics shows the Omicron variant has caused six to eight times the rate of Omicron infections in US preschoolers as the Delta variant, but cases were less severe with Omicron.
Studies in Brazil and Sweden show good efficacy against illness and hospitalization.
Incidence was 2 to 6 times higher after SARS-CoV-2 infection than after the second vaccine dose.
Throat swabs revealed fewer antibiotic resistance genes with shorter treatment.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A study of Escherichia coli isolates from young hospitalized children in western Kenya found high levels of antimicrobial resistance (AMR), researchers reported yesterday in PLOS Neglected Tropical Diseases.
Three new studies to be presented at the upcoming European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) conference at the end of the month demonstrate benefits of the antiviral molnupiravir against COVID-19 infections, including evidence that Merck's pill reduces symptoms of the SARS-CoV-2 virus by day 3 of administration.
